Your browser doesn't support javascript.
loading
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group.
van de Loosdrecht, Arjan A; Kern, Wolfgang; Porwit, Anna; Valent, Peter; Kordasti, Sharham; Cremers, Eline; Alhan, Canan; Duetz, Carolien; Dunlop, Alan; Hobo, Willemijn; Preijers, Frank; Wagner-Ballon, Orianne; Chapuis, Nicolas; Fontenay, Michaela; Bettelheim, Peter; Eidenschink-Brodersen, Lisa; Font, Patricia; Johansson, Ulrika; Loken, Michael R; Te Marvelde, Jeroen G; Matarraz, Sergio; Ogata, Kiyoyuki; Oelschlaegel, Uta; Orfao, Alberto; Psarra, Katherina; Subirá, Dolores; Wells, Denise A; Béné, Marie C; Della Porta, Matteo G; Burbury, Kate; Bellos, Frauke; van der Velden, Vincent H J; Westers, Theresia M; Saft, Leonie; Ireland, Robin.
Afiliação
  • van de Loosdrecht AA; Department of Hematology, Amsterdam UMC, location VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Kern W; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Porwit A; Department of Clinical Sciences, Division of Oncology and Pathology, Faculty of Medicine, Lund University, Lund, Sweden.
  • Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Kordasti S; Comprehensive Cancer Centre, King's College London, London, UK.
  • Cremers E; Department of Internal Medicine, Division of Hematology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Alhan C; Department of Hematology, Amsterdam UMC, location VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Duetz C; Department of Hematology, Amsterdam UMC, location VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Dunlop A; Department of Haemato-Oncology, Royal Marsden Hospital, London, UK.
  • Hobo W; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Preijers F; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Wagner-Ballon O; Department of Hematology and Immunology, Assistance Publique-Hôpitaux de Paris, University Hospital Henri Mondor, Créteil, France.
  • Chapuis N; Université Paris-Est Créteil, Inserm U955, Créteil, France.
  • Fontenay M; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Centre-Université de Paris, Paris, France.
  • Bettelheim P; Institut Cochin, Université de Paris, INSERM U1016, CNRS UMR 8104, Paris, France.
  • Eidenschink-Brodersen L; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Centre-Université de Paris, Paris, France.
  • Font P; Institut Cochin, Université de Paris, INSERM U1016, CNRS UMR 8104, Paris, France.
  • Johansson U; Department of Hematology, Ordensklinikum Linz, Elisabethinen, Linz, Austria.
  • Loken MR; HematoLogics, Inc., Seattle, Washington, USA.
  • Te Marvelde JG; Department of Hematology, Hospital General Universitario Gregorio Marañon - IiSGM, Madrid, Spain.
  • Matarraz S; Laboratory Medicine, SI-HMDS, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
  • Ogata K; HematoLogics, Inc., Seattle, Washington, USA.
  • Oelschlaegel U; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Orfao A; Cancer Research Center (CIC/IBMCC-USAL/CSIC), Department of Medicine and Cytometry Service, University of Salamanca, Institute for Biomedical Research of Salamanca (IBSAL) and CIBERONC, Salamanca, Spain.
  • Psarra K; Metropolitan Research and Treatment Centre for Blood Disorders (MRTC Japan), Tokyo, Japan.
  • Subirá D; Department of Internal Medicine, University Hospital Carl-Gustav-Carus TU Dresden, Dresden, Germany.
  • Wells DA; Cancer Research Center (CIC/IBMCC-USAL/CSIC), Department of Medicine and Cytometry Service, University of Salamanca, Institute for Biomedical Research of Salamanca (IBSAL) and CIBERONC, Salamanca, Spain.
  • Béné MC; Department of Immunology - Histocompatibility, Evangelismos Hospital, Athens, Greece.
  • Della Porta MG; Department of Hematology, Flow Cytometry Unit, Hospital Universitario de Guadalajara, Guadalajara, Spain.
  • Burbury K; HematoLogics, Inc., Seattle, Washington, USA.
  • Bellos F; Hematology Biology, Nantes University Hospital and CRCINA, Nantes, France.
  • van der Velden VHJ; IRCCS Humanitas Research Hospital, Milan, Italy.
  • Westers TM; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Saft L; Department of Haematology, Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, Australia.
  • Ireland R; MLL Munich Leukemia Laboratory, Munich, Germany.
Cytometry B Clin Cytom ; 104(1): 77-86, 2023 01.
Article em En | MEDLINE | ID: mdl-34897979
ABSTRACT
This article discusses the rationale for inclusion of flow cytometry (FCM) in the diagnostic investigation and evaluation of cytopenias of uncertain origin and suspected myelodysplastic syndromes (MDS) by the European LeukemiaNet international MDS Flow Working Group (ELN iMDS Flow WG). The WHO 2016 classification recognizes that FCM contributes to the diagnosis of MDS and may be useful for prognostication, prediction, and evaluation of response to therapy and follow-up of MDS patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas Limite: Humans Idioma: En Revista: Cytometry B Clin Cytom Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas Limite: Humans Idioma: En Revista: Cytometry B Clin Cytom Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda